Skip to main content

Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation

Published: 23 June 2017

The Respiratory Medicine Journal presents a new study demonstrating the prognostic value of CPET test parameters as pre-assessment tool for lung transplant ILD patients.

The purpose of this work was to determine if parameters assessed during Cardiopulmonary Exercise Testing (CPET) while using supplemental oxygen can independently predict one-year transplant- free survival in patients with Interstitial Lung Disease (ILD) referred for lung transplant evaluation.

The study comprised a chart review of patients with ILD who completed CPET with 30% FiO2 and gathered spirometry, pulmonary hemodynamic, six-minute walk, and CPET data. The primary end-point was death or lung transplantation within one-year of CPET.

The findings of this research "demonstrate the potential of added prognostic value in measuring peak workload and nadir SpO2 by CPET to identify patients who have an increased likelihood of clinical deterioration and death".

The article details are the following:

Title: "Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation"
Authors: Layton AM, Armstrong HF, Kim HP, Meza KS, D'Ovidio F, Arcasoy SM
- Published in
: Respir Med. 2017 May;126:59-67

The study can be purchased at the following link: click here

Get in touch

COSMED strives to provide the best service possible with every contact!

Fill the online forms to get the info you're looking for right now!

Register your Product

Register your Product

Fill the online form to get software upgrades and more advantages

Read more

Request for information

Request for information

Fill the online form to get more information or a quote 

Read more

Request for Support

Request for Support

Fill the online form in order to help us fully understand your problem

Read more

COSMED LOGO
COSMED LOGO

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

COSMED is a world leading supplier of Cardio Pulmonary, Metabolic and Body Composition testing solutions to Sports Science, Medicine, Professional Sport and Wellness.

FOLLOW US ON

FOLLOW US ON